AIM2 and NLRC4-driven inflammasome activation in adult-onset Still’s disease and the preliminary therapeutic effect exploration of carboxyamidotriazole-Reference-Cited by-同舟云学术

AIM2 and NLRC4-driven inflammasome activation in adult-onset Still’s disease and the preliminary therapeutic effect exploration of carboxyamidotriazole

Published:2022-11-24 Issue: Volume: Page:
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Duan Mengyuan,Shen Min,Zhou Yongting,He Yi,Guo Zehao,Ye Caiying,Li Juan,Zhu Lei^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-022-06443-1.pdf

Reference40 articles.

1. Wang M, Liu M, Jia J, Shi H, Teng J, Liu H et al (2021) Association of the leukocyte immunoglobulin-like receptor A3 gene with neutrophil activation and disease susceptibility in adult-onset Still’s disease. Arthritis Rheumatol 73:1033–1043. https://doi.org/10.1002/art.41635

2. Maranini B, Ciancio G, Govoni M (2021) Adult-onset Still’s disease: novel biomarkers of specific subsets, disease activity, and relapsing forms. Int J Mol Sci 22:13320. https://doi.org/10.3390/ijms222413320

3. Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P (2021) Adult-onset Still’s disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum 51:858–874. https://doi.org/10.1016/j.semarthrit.2021.06.004

4. Yoo DH (2017) Treatment of adult-onset still’s disease: up to date. Expert Rev Clin Immunol 13:849–866. https://doi.org/10.1080/1744666X.2017.1332994

5. Feist E, Mitrovic S, Fautrel B (2018) Mechanisms, biomarkers and targets for adult-onset Still’s disease. Nat Rev Rheumatol 14:603–618. https://doi.org/10.1038/s41584-018-0081-x

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An effective LC–MS method for the simultaneous determination of a potential anti‐rheumatoid arthritis drug, carboxyamidotriazole, and its major metabolite in rat plasma;Biomedical Chromatography;2024-06-04